Chicago, Oct. 19, 2022 (GLOBE NEWSWIRE) -- According to the new market research report "Clinical Trial Imaging Market by Software & Services(Operational Imaging, Read Analysis), Modality(CT, MRI, X-ray, PET, Ultrasound, ECHO), Therapeutic Areas(Infectious, Oncology, CNS, CVS), End user(Pharma, biotechnology, CRO) - Global Forecast to 2026", is projected to reach USD 1.4 billion by 2026 from USD 1.0 billion in 2021, at a CAGR of 7.6%.
Browse and in-depth TOC on "Clinical Trial Imaging Market"
198- Tables
38- Figures
206- Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=30446624
Scope of the Clinical Trial Imaging Market:
| Report Metric | Details |
| Market Size | USD 1.4 billion by 2026 |
| CAGR | 7.6% |
| Historical Data | 2019-2020 |
| Base Year | 2020 |
| Forecast Period | 2021-2026 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | By Product and service, By modality, By therapeutic area, By End-User, By Geography |
| Geographies Covered | North America, Europe, Asia-Pacific, LAME and Rest of the World |
| Key Companies Profiled/Vendors | ICON plc. (Ireland) | BioTelemetry Inc. (US) | Biomedical Systems Corporation (US) | Medpace Holdings | Inc. (US) | IXICO plc. (UK) | Resonance Health Ltd. (Australia) | Radiant Sage LLC. (US) | BioClinica Inc. (US) | Intrinsic Imaging LLC. (US) | Cardiovascular Imaging Technologies LLC. (US) | Medical Metrics Inc. (US) | Prism Clinical Imaging | Inc. (US) | Boston Imaging Core Lab LLC. (US) | anagram 4 clinical trials (Spain) | Lyscaut Medical Imaging Company (Belgium) | Calyx Group (UK) | Bioseptive Inc. (Canada) | ProScan Imaging LLC. (US) | Micron Inc. (Japan) | Imaging Endpoints LI | LLC (US) | Perspectum Ltd. (UK) | Pharmtrace klinische Entwicklung GmbH (Germany) | WorldCare Clinical LLC (US). |
| Key Market Opportunities | Developing Countries |
| Key Market Drivers | Driver: Increase in R&D spending |
The Increasing number of CROs, increase in R&D spending, growth in pharmaceutical and biotechnology market are the major factors driving the market’s growth.
Based on product and services, the clinical trial imaging market is segmented into services and software. In 2020, the software segment accounted for the largest share of the market, mainly due to increased R&D spending and growth in pharmaceutical and biotechnology industries.
Based on modality, the clinical trial imaging market is segmented into computed tomography, magnetic resonance imaging, ultrasound, positron emission tomography, X-ray, echocardiography and other modalities. In 2020, the computed tomography segment accounted for the largest share of the market. The large share of this segment can mainly be attributed to theincreasing number of CROs and increased R&D spending.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=30446624
Based on therapeutic area, the clinical trial imaging market has been segmented into oncology, infectious diseases, neurology, CVS, endocrinology, immunological disorder and another therapeutic area. In 2020, the oncology segment accounted for the largest share of the market, mainly due to the increasing R&D spending and growth in pharmaceutical and biotechnology industries.
Based on end users, the clinical trial imaging market has been segmented into pharmaceutical companies, biotechnology companies, medical device manufacturers, contract research organizations, academic and government research institute sand other end users. In 2020, the pharmaceutical companies segment accounted for the largest share of the market, mainly due to the increasing number of CROs and growth in pharmaceutical and biotechnology industries.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=30446624
Geographical Growth Scenario:
The global clinical trial imaging market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest regional market for market in 2020. The large share of North America in this market can be attributed to the increasing number of CROs, growth in pharmaceutical and biotechnology industries and increased R&D spending.
Key Players:
The major players operating in this clinical trial imaging market are ICON plc. (Ireland), BioTelemetry Inc. (US), Biomedical Systems Corporation (US), Medpace Holdings, Inc. (US), IXICO plc. (UK), Resonance Health Ltd. (Australia), Radiant Sage LLC. (US), BioClinica Inc. (US), Intrinsic Imaging LLC. (US), Cardiovascular Imaging Technologies LLC. (US), Medical Metrics Inc. (US), Prism Clinical Imaging, Inc. (US), Boston Imaging Core Lab LLC. (US), anagram 4 clinical trials (Spain), Lyscaut Medical Imaging Company (Belgium), Calyx Group (UK), Bioseptive Inc. (Canada), ProScan Imaging LLC. (US), Micron Inc. (Japan), Imaging Endpoints LI, LLC (US), Perspectum Ltd. (UK), Pharmtrace klinische Entwicklung GmbH (Germany), WorldCare Clinical, LLC (US).
Browse Adjacent Markets@ Medical Devices Market Research Reports & Consulting
Browse Related Reports:
Diagnostic Imaging Market - Global Forecast to 2026
Contract Research Organization (CROs) Services Market - Global Forecast to 2027
Clinical Trial Supplies Market - Global Forecast 2026
eClinical Solutions Market - Global Forecasts to 2026
Clinical Trial Management System/CTMS Market - Global Forecasts to 2025
